146 related articles for article (PubMed ID: 23885741)
1. South African recommendations for the management of rheumatoid arthritis: an algorithm for the standard of care in 2013.
Hodkinson B; Van Duuren E; Pettipher C; Kalla A;
S Afr Med J; 2013 Jun; 103(8 Pt 2):576-85. PubMed ID: 23885741
[TBL] [Abstract][Full Text] [Related]
2. Response to traditional disease-modifying anti-rheumatic drugs in indigent South Africans with early rheumatoid arthritis.
Hodkinson B; Musenge E; Ally M; Meyer PW; Anderson R; Tikly M
Clin Rheumatol; 2012 Apr; 31(4):613-9. PubMed ID: 22134750
[TBL] [Abstract][Full Text] [Related]
3. [Rheumatoid arthritis (updated Current Care guideline)].
Hakala M; Hannonen P; Helve T; Korpela M; Mattila K; Möttönen T; Varis T;
Duodecim; 2009; 125(19):2131-2. PubMed ID: 19938416
[TBL] [Abstract][Full Text] [Related]
4. [The meaning of biologic therapy in the treatment of rheumatoid arthritis with the focus on clinical remission. Part I. Tumor necrosis factor alpha inhibitors].
Swierkot J; Madej M
Pol Merkur Lekarski; 2011 Apr; 30(178):283-8. PubMed ID: 21595176
[TBL] [Abstract][Full Text] [Related]
5. Progression in early rheumatoid arthritis.
Combe B
Best Pract Res Clin Rheumatol; 2009 Feb; 23(1):59-69. PubMed ID: 19233046
[TBL] [Abstract][Full Text] [Related]
6. How aggressive should initial therapy for rheumatoid arthritis be? Factors associated with response to 'non-aggressive' DMARD treatment and perspective from a 2-yr open label trial.
Matteson EL; Weyand CM; Fulbright JW; Christianson TJ; McClelland RL; Goronzy JJ
Rheumatology (Oxford); 2004 May; 43(5):619-25. PubMed ID: 14983105
[TBL] [Abstract][Full Text] [Related]
7. Contemporary use of disease-modifying drugs in the management of patients with early rheumatoid arthritis in Norway.
Nikolaisen C; Kvien TK; Mikkelsen K; Kaufmann C; Rødevand E; Nossent JC
Scand J Rheumatol; 2009; 38(4):240-5. PubMed ID: 19229766
[TBL] [Abstract][Full Text] [Related]
8. Adalimumab, a fully human anti tumor necrosis factor-alpha monoclonal antibody, and concomitant standard antirheumatic therapy for the treatment of rheumatoid arthritis: results of STAR (Safety Trial of Adalimumab in Rheumatoid Arthritis).
Furst DE; Schiff MH; Fleischmann RM; Strand V; Birbara CA; Compagnone D; Fischkoff SA; Chartash EK
J Rheumatol; 2003 Dec; 30(12):2563-71. PubMed ID: 14719195
[TBL] [Abstract][Full Text] [Related]
9. Remission in rheumatoid arthritis: wishful thinking or clinical reality?
Sesin CA; Bingham CO
Semin Arthritis Rheum; 2005 Dec; 35(3):185-96. PubMed ID: 16325659
[TBL] [Abstract][Full Text] [Related]
10. 2012 Brazilian Society of Rheumatology Consensus for the treatment of rheumatoid arthritis.
da Mota LM; Cruz BA; Brenol CV; Pereira IA; Rezende-Fronza LS; Bertolo MB; de Freitas MV; da Silva NA; Louzada-Júnior P; Giorgi RD; Lima RA; da Rocha Castelar Pinheiro G;
Rev Bras Reumatol; 2012; 52(2):152-74. PubMed ID: 22460407
[TBL] [Abstract][Full Text] [Related]
11. Response-driven combination therapy with conventional disease-modifying antirheumatic drugs can achieve high response rates in early rheumatoid arthritis with minimal glucocorticoid and nonsteroidal anti-inflammatory drug use.
Proudman SM; Keen HI; Stamp LK; Lee AT; Goldblatt F; Ayres OC; Rischmueller M; James MJ; Hill CL; Caughey GE; Cleland LG
Semin Arthritis Rheum; 2007 Oct; 37(2):99-111. PubMed ID: 17391739
[TBL] [Abstract][Full Text] [Related]
12. DMARDs in the treatment of rheumatoid arthritis: current agents and future developments.
Simon LS
Int J Clin Pract; 2000 May; 54(4):243-9. PubMed ID: 10912314
[TBL] [Abstract][Full Text] [Related]
13. Management of early rheumatoid arthritis.
Suresh E
J Assoc Physicians India; 2007 May; 55():355-62. PubMed ID: 17844697
[TBL] [Abstract][Full Text] [Related]
14. Challenges and opportunities in the early diagnosis and optimal management of rheumatoid arthritis in Africa and the Middle East.
Halabi H; Alarfaj A; Alawneh K; Alballa S; Alsaeid K; Badsha H; Benitha R; Bouajina E; Al Emadi S; El Garf A; El Hadidi K; Laatar A; Makhloufi CD; Masri AF; Menassa J; Al Shaikh A; Swailem RA; Dougados M
Int J Rheum Dis; 2015 Mar; 18(3):268-75. PubMed ID: 24620997
[TBL] [Abstract][Full Text] [Related]
15. [Rheumatoid arthritis: current status of therapy].
El Bahri DM; Meddeb N; Sellami S
Tunis Med; 2007 Jan; 85(1):1-8. PubMed ID: 17424701
[TBL] [Abstract][Full Text] [Related]
16. Predictors of response to anti-TNF-alpha therapy among patients with rheumatoid arthritis: results from the British Society for Rheumatology Biologics Register.
Hyrich KL; Watson KD; Silman AJ; Symmons DP;
Rheumatology (Oxford); 2006 Dec; 45(12):1558-65. PubMed ID: 16705046
[TBL] [Abstract][Full Text] [Related]
17. Early rheumatoid arthritis: strategies for prevention and management.
Combe B
Best Pract Res Clin Rheumatol; 2007 Feb; 21(1):27-42. PubMed ID: 17350542
[TBL] [Abstract][Full Text] [Related]
18. Assessment and management of rheumatoid arthritis.
Haraoui B
J Rheumatol Suppl; 2009 Jun; 82():2-10. PubMed ID: 19509324
[TBL] [Abstract][Full Text] [Related]
19. Efficacy and safety of methotrexate in combination with other non-biologic disease-modifying antirheumatic drugs (DMARDs) in treatment of rheumatoid arthritis.
Castrejón I; Gibson KA; Pincus T
Bull Hosp Jt Dis (2013); 2013; 71 Suppl 1():S20-8. PubMed ID: 24219037
[TBL] [Abstract][Full Text] [Related]
20. Cost effectiveness of adding leflunomide to a 5-year strategy of conventional disease-modifying antirheumatic drugs in patients with rheumatoid arthritis.
Maetzel A; Strand V; Tugwell P; Wells G; Bombardier C
Arthritis Rheum; 2002 Dec; 47(6):655-61. PubMed ID: 12522841
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
